



314A ABSTRACTS- Myocardial Ischemia and I n fa rc t ion  
of 30-day mortality among diabetics. Conclualone: Despite the contemporary manage- 
ment, diabetic patients wffh non-ST-segment elevation acute coronary syndromes have 
almost doubled 30-day mortality than nondiabetica. 
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840-5 In-Hospital Outcome of Acute Myocardial Infarction in 
Patients With Prior Coronary Artery Bypass Surgery: A 
Study From NRMI 3 
Verahese Mathew. Bernard J. Gersh, Hal Barren, Nathan Every, Alan T~efenbrunn, Paul 
Frederick, Judith Malmgren, For the NRMI Investigators, Mayo Clinic and Foundation, 
Rochester, Minnesota. 
Background: Patients with coronary artery bypass grafting (CABG) comprise an increas- 
ing proportion of acute myocardial infarction (MI) patients. Data regarding the influence 
of prior CABG on survival after MI is discordant; the influence of sinus tachycardia (ST) 
segment shift (ST elevation vs non-ST elevation) on outcome has not been examined in 
this population. We sought to describe the characteristics of patients with and without 
prior CABG presenting with acute MI, with or without ST segment elevation/left bundle 
branch block (LBBB), and to evaluate the effect of ST segment shift on in-hospital mortal- 
ity in patients with prior CABG. 
Methods: Utilizing the NRMI-3 Registry, we identified 112,697 patients with acute Mt with- 
out exclusion criteria. Of these, 15,936 (14.t%) had prior CABG. 
Results: Patients with prior CABG had more adverse baseline characteristics, and were 
less likely to present with ST elevation/LBBB than patients without prior CABG. The 
unadjusted mortality for ST elevation/LBBB patients was higher in patients with prior 
CABG compared to those without (16.2% vs 14.1%, P=0.0001) whereas in patients with- 
out ST elevation/LBBB, prior CASG patients had a lower unadjusted mortality than 
patients without prior CABG (10.1% vs 12.4%, P=0.0001). Adjusting for baseline differ- 
ences, prior CABG was weakly associated with in-hospital mortality in patients present- 
ing with ST elevation/LBBB (odds ratio (OR), 1.11, 96% confidence intervals (CI) 1.00- 
1.23), whereas prior CABG did not correlate with in-hospital mortality in patients present- 
ing without ST elevation/LBSB (OR 0.99, 96% CI 0.92-1.07). 
Conclusion: Patients with prior CABG who present with acute MI are more likely to 
present without ST etevation/LBBB, as compared to patients without phor CABG. Prior 
CABG was weakly associated with in-hospital mortality in patients with ST elevation/ 
LBBB, but did not influence in-hospital mortality in patients without these electrocardio- 
graphic findings. This suggests the difference in absolute mortality rates between 
patients presenting with MI with and without a history of prior CABG are in large part due 
to differences in baseline characteristics, 
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840-6 Cardiovascular Manifestations of Carbon Monoxide 
Poisoning 
Daniel Satran. Christopher R. Henry, Caren I. Chaney, Cheryl D. Adkinson, Timothy D. 
Henry, Hennepin County Medical Center, Minneapolis, Minnesota, University of 
Minnesota, Minneapolis, Minnesota. 
Carbon monoxide (CO) poisoning is a common cause of morbidity and mortality. While 
the neurologic sequelae of CO poisoning have been described, the cardiovascular com- 
plications are limited to isolated case reports. Methods: We reviewed the cardiovascular 
manifestations of 216 consecutive patients(Pts) treated for severe CO poisoning in the 
hyperbaric oxygen chamber at Hennepin County Medical Center, a regional center for 
treatment of CO poisoning. Results: The mean age was 47.2 years. 35 (16.4%) Pts had a 
normal baseline EKG; 94 (44.1%) sinus tachycardia; 85 (39.9%) non-specific ST 
changes; 63 (29.6%) ischemic changes, including 53 (24.8%) with dynamic ST or T wave 
changes and 10 (4.7%) with ST elevation. Of the 171 pts with cardiac enzymes, 75 
(34.7% of the total) were diagnostic of myocardial injury (CK-MB mass >5.0 ng/ml or 
troponin I >0.7 ng/ml). An additional 4 pts had EKG changes diagnostic of myocardial 
injury, but without cardiac enzymes. Of the 49 pts with echocardiograms, 27 (55.1%) had 
decreased left ventricular (LV) function. Of those 27, 14 had global wall motion abnormal- 
ity (WMA), and 13 had regional WMA. An additional 16 had RV dysfunction. In hospital 
mortality was only 3.7% (n=8), the most common cause being anoxic brain and burn 
injury (n=5). 3 Pts had an out of hospital cardiac arrest leading to anoxic brain injury and 
death. Two clear patterns of myocardial injury were identified. Older Pts with cardiac risk 
factors or previous CAD were more likely to have regional WMA with myocardial injury 
related to CAD. In contrast, another group was younger, without evidence of CAD, and 
more likely to have reversible global LV dysfunction. Conclusions: This is the first system- 
atic description of cardiovascular manifestations of CO poisoning. Cardiovascular 
sequelae of severe CO poisoning are frequent (36.6% with myocardial injury) and often 
unrecognized but mortality is related to noncardiac causes. Pts admitted with severe CO 
poisoning should have a baseline EKG and serial cardiac enzymes. Pts with EKG 
JACC March  6, 2002 
changes or elevated enzymes should have an echocardiogram. Pts with myocardial 
injury in association with cardiac risk factors, previous CAD or persistent LV dysfunction 
deserve further evaluation. 
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841-1 Outcome After Acute Myocardial Infarction In Young 
Patients: Analysis of the PAMI Database 
Roberto A. Comus. Jr., Judith A. Boura, Gregg W. Stone, Bruce R. Brodie, David A. Cox, 
Eulogio Garcia, Lori L Grines, William W. O'Neill, Cindy L. Grines, William Beaumont 
Hospital, Royal Oak, Michigan. 
Background: Acute myocardial infarction (AMI) in patients (pts) < 40 years old (y/o) is 
uncommon. Few data exist regarding the outcome of these pts after percutaneous inter- 
vention (PCI) for AMI. 
Methods: This analysis pooled pts from 7 PAMI studies for a total of 4017 pts. Pts < 40 y/ 
o (N=171) were compared to pts > 40 y/o (N=3846). In-hospital, 6 month and 1 year out- 
comes are reported. 
Results: Younger pts were more often male and had a significantly higher incidence of 
smoking and family history of CAD, but a lower incidence of hypertension, diabetes, 
stroke, and prior coronary intervention compared to pts > 40 y/o. Younger pts had larger 
infarct sizes as measured by peak CPK (2974 vs. 2016, p=0.003) but no significant differ- 
ence in ejection fraction at baseline (50% vs. 48%) or 6 months (54% vs. 55%) compared 
to older pts. Younger pts had less muitivessel disease (p<0.001) and greater achieve- 
ment of TIMI 3 flow (99% vs. 92%, p=0.006) after PCI. While pts < 40 y/o had less mor- 
tality compared to older pts, recurrent AMI was significantly higher in the younger 
population (p=0.012). 
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In multivariate analysis, age _< 40 was the most significant predictor of re-infarction at 1 
year (OR=3.62 [95%C1: 1.794-7.296], p=0.0003. 
Conclusions: While pts _< 40 years old have improved survival after AMI, they have an 
increased rate of nonfatal re-infarction at 1 year compared to older pts. These data sug- 
gest the need for comprehensive diagnostic evaluation, aggressive nsk factor modifica- 
tion, and intensive follow-up in young pts with AMI. 
8:45 a.m. 
841-2 Interleukln-1 Beta Predicts Death or Myocardial 
Infarction Independently of High-Sensitivity C-Reactive 
Protein and Standard Risk Factors in Patients With 
Coronary Artery Disease 
Jason M. Laooe'. Joseph B. Muhlestein, John F. Cadquist, Brent P. Davis, Benjamin D. 
Home, Jeffrey L. Anderson, LDS Hospital, Salt Lake City Utah, University of Utah, Salt 
Lake City, Utah. 
Background: Intarleukin (IL)-I beta, tumor necrosis factor alpha (TNFalpha) and IL-6 
are important proinflammatory cytokines. IL-6 is produced in response to ~L-1 and TNFal- 
pha and is one of the major inducers of C-reactive protein (CRP). Elevated high-sensitiv- 
ity (hs)CRP is associated with an increased risk of death and MI in patients with 
CAD.The objective of this study was to determine whether IL-1, IL-6 or TNFalpha also 
independently predict death or MI in CAD patients. 
Methods: A nested case control study evaluating levels of IL-1 beta, IL-6, TNFalpha, and 
hsCRP (measured on the automated DPC Immulita platform) in 334 patients with signifi- 
cant, angiographically-proven coronary artery disease (>1 lesion of ->70% stenosis) was 
performed. Overall, 167 patients died or had an MI (cases), and 167 patients were event- 
free (controls). Cases were matched 1:1 to controls by age, gender, and time period of 
angiogram. Other cardiovascular hsk factors were recorded and patients followed for 
3.6~O.75 years (range: 2.0-5.0 years). 
Results: Average age was 69.6+9.9 years and 74% of patients were male. In multivad- 
able Cox regression controlling for 11 co-variables, hsCRP (hazard ratio [HR]= 1.24 per 
tertile, 95% confidence interval [CI]= 1.02-1.5, p=0.03) and IL-1 beta (HR=1.32 per tartile, 
CI= 1.08-1.6, p=0.008) were independently predictive of deatWIVll, but IL-6 (p=0.36, 
tracked with hsCRP) and TNFalpha (p=0.97) did not predict events. IL-6 and hsCRP 
were mildly correlated (r=0.38) and IL-1 beta nominally correlated with TNFalpha 
(r=0.24). No cytokine nor hsCRP was correlated with cholestarol evels. When analyzed 
jointly, having a high hsCRP (tertile 2,3) and high IL-1 beta (tertile 3) predicted a marked 
increase in events (HR=5.3, p<0.001) compared to low hsCRP (tertile 1) and low IL-1 
beta (tertile 1). 
